MICROCHIP TECHNOLOGY INCORPORATED (Exact Name Of Registrant As Specified In Its Charter) |
Delaware | 0-21184 | 86-0629024 |
(State or other Jurisdiction of Incorporation) | (Commission File No.) | (IRS Employer Identification No.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
þ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
(d) | Exhibits | |
99.1 | Joint Press Release issued on May 2, 2012 (Microchip Technology and SMSC Announce the Acquisition of SMSC by Microchip Technology) | |
99.2 | Press Release issued on May 1, 2012 (Microchip Technology Announces Fourth Quarter and Fiscal Year 2012 Financial Results) |
Dated: May 2, 2012 | Microchip Technology Incorporated |
By: /s/ J. Eric Bjornholt | |
J. Eric Bjornholt Vice President and Chief Financial Officer |
99.1 | Joint Press Release issued on May 2, 2012 (Microchip Technology and SMSC Announce the Acquisition of SMSC by Microchip Technology) |
99.2 | Press Release issued on May 1, 2012 (Microchip Technology Announces Fourth Quarter and Fiscal Year 2012 Financial Results) |
EXHIBIT 99.1 NEWS RELEASE | |
![]() | ![]() |
MICROCHIP CONTACTS: | SMSC CONTACT: |
J. Eric Bjornholt - CFO(480) 792-7804 Gordon Parnell - Vice President of Business Development and Investor Relations.......(480) 792-7374 | Carolynne Borders - Vice President, Corporate Communications and Investor Relations (631) 435-6626 |
![]() | EXHIBIT 99.2 NEWS RELEASE INVESTOR RELATIONS CONTACTS: J. Eric Bjornholt - CFO(480) 792-7804 Gordon Parnell - Vice President of Business Development and Investor Relations(480) 792-7374 |
• | FOR FISCAL YEAR 2012: |
▪ | NET SALES OF $1.383 BILLION |
▪ | ON A GAAP BASIS: |
• | GROSS MARGIN OF 57.3%; OPERATING INCOME OF $396.5 MILLION; NET INCOME OF $336.7 MILLION AND 24.3% OF NET SALES; EPS OF $1.65 PER DILUTED SHARE |
▪ | ON A NON-GAAP BASIS: |
• | GROSS MARGIN OF 58.2%; OPERATING INCOME OF $447.4 MILLION; NET INCOME OF $383.7 MILLION AND 27.7% OF NET SALES; EPS OF $1.89 PER DILUTED SHARE |
• | FOR THE QUARTER ENDING MARCH 31, 2012: |
▪ | NET SALES OF $338.9 MILLION, UP 3.0% SEQUENTIALLY |
▪ | ON A GAAP BASIS: |
• | GROSS MARGIN OF 57.2%; OPERATING INCOME OF $93.9 MILLION; NET INCOME OF $80.6 MILLION AND 23.8% OF NET SALES; EPS OF 39 CENTS PER DILUTED SHARE. THERE WAS NO PUBLISHED FIRST CALL ESTIMATE FOR GAAP EPS. |
▪ | ON A NON-GAAP BASIS: |
• | GROSS MARGIN OF 58.1%; OPERATING INCOME OF $108.0 MILLION; NET INCOME OF $94.3 MILLION AND 27.8% OF NET SALES; EPS OF 46 CENTS PER DILUTED SHARE. THE FIRST CALL PUBLISHED ESTIMATE WAS 45 CENTS FOR NON-GAAP EPS. |
▪ | RECORD QUARTERLY SHIPMENTS OF 50,405 DEVELOPMENT TOOLS. |
Three Months Ended March 31, 2012 | Year Ended March 31, 2012 | |||||||||||||||
(in millions, except earnings per diluted share and percentages) | GAAP | % of Net Sales | Non-GAAP1 | % of Net Sales | GAAP | % of Net Sales | Non-GAAP1 | % of Net Sales | ||||||||
Net Sales | $ | 338.9 | $ | 338.9 | $ | 1,383.2 | $ | 1,383.2 | ||||||||
Gross Margin | $ | 193.9 | 57.2% | $ | 196.9 | 58.1% | $ | 792.4 | 57.3% | $ | 804.9 | 58.2% | ||||
Operating Income | $ | 93.9 | 27.7% | $ | 108.0 | 31.9% | $ | 396.5 | 28.7% | $ | 447.4 | 32.3% | ||||
Other Expense including Gains/Losses on Equity Method Investments | $ | 2.0 | $ | 0.1 | $ | 16.8 | $ | 7.4 | ||||||||
Income Tax Expense (benefit) | $ | 11.3 | $ | 13.6 | $ | 43.0 | $ | 56.3 | ||||||||
Net Income | $ | 80.6 | 23.8% | $ | 94.3 | 27.8% | $ | 336.7 | 24.3% | $ | 383.7 | 27.7% | ||||
Earnings per Diluted Share2 | 39 cents | 46 cents | $ | 1.65 | $ | 1.89 |
2 | Earnings per share have been calculated based on the diluted shares outstanding of Microchip on a consolidated basis. |
• | The Company was named a finalist in the EE Times/EDN ACE Awards for its MPLAB® X IDE, in the Software category, and for its MTD6505 Fan Driver in the Analog ICs category. |
• | Building on the success of its MPLAB X IDE, Microchip’s introduced the new MPLAB XC, which is a simplified C compiler line that provides the best execution speed and code size for all PIC® MCUs and dsPIC® DSCs. |
• | Microchip shipped a record 50,405 development systems during the quarter, demonstrating the continued strong interest in its products. The total cumulative number of development systems shipped now stands at 1,293,567. |
• | The Company acquired Ident Technology AG, a German based company that is developing advanced gesture recognition solutions. This acquisition builds upon Microchip’s strengths in proximity, touch sense and touch screen controller solutions for the embedded market. |
• | The Company acquired Roving Networks to expand its wireless offerings with additional embedded Wi-Fi® capabilities and new Bluetooth® connectivity options for PIC microcontrollers. |
• | In other wireless news, Microchip continued to grow the portfolio of RF products with its smallest front-end module for 802.11b/g/n Wi-Fi, as well as Bluetooth systems. |
• | Microchip demonstrated continued investment in its primary 8-bit product line with two new families that feature high levels of cost-effective advanced analog and digital integration, including 12-bit ADC, 8-bit DAC, op amps, high-speed comparators, eXtreme Low Power technology, a Complementary Output Generator peripheral that provides non-overlapping, complementary waveforms for inputs, and a 16-bit PWM with the industry’s highest level of advanced control. |
• | Microchip continued filling out its 16-bit MCU portfolio on both ends of the spectrum, with its new lowest-cost PIC24 Lite line for consumer, medical and safety/security applications on one end, and the upgrade of its enhanced-core dsPIC33E and PIC24E to 70 MIPS performance, on the other end. To enable advanced remote-control designs using its 16-bit MCUs and ZigBee® wireless transceivers, Microchip introduced a demo board that showcases graphics, touch sensing, USB and wireless connectivity. |
• | Microchip’s 32-bit PIC32 MCU portfolio added new members to the smallest and lowest-cost family, which are the first PIC32s to feature dedicated audio and capacitive-sensing peripherals. Additionally, the new Wi-Fi Comm Demo Board makes it easy to evaluate the combination of PIC32s with Microchip’s Wi-Fi modules and free TCP/IP stack. |
• | On the analog front, Microchip introduced a USB to SPI protocol converter that provides the simplest, smallest and most cost-effective way to add USB to existing designs. |
• | The Company’s memory portfolio also expanded, with a lower-cost real-time clock that has 64 Bytes of SRAM and a digital-trimming circuit for higher accuracy. Additionally, Microchip introduced a new |
Microchip Guidance | |||
GAAP | Non-GAAP Adjustments1 | Non-GAAP1 | |
Results from Continuing Operations: | |||
Net Sales | $349.1 to $362.6 million | $349.1 to $362.6 million | |
Gross Margin3 | 58.0% to 58.25% | $3.5 to $3.6 million | 59.0% to 59.25% |
Operating Expenses3 | about 29.25% | $10.5 to $10.9 million | about 26.25% |
Other Income (Expense) | ($4.5) million | $2.0 million | ($2.5) million |
Tax Rate | 12.75% to 13.25% | $2.4 million | 13.0% to 13.5% |
Net Income | $83.2 to $87.9 million | $13.5 to $14.0 million | $96.7 to $101.9 million |
Diluted Common Shares Outstanding2 | 206.3 million shares | 0.5 million shares | 205.8 million shares |
Earnings per Diluted Share | 40 to 42 cents | about 7 cents | 47 to 49 cents |
• | Microchip’s inventory days at June 30, 2012 are expected to be about flat from the March quarter. Our inventory position enables us to continue to service our customers with very short lead times while allowing us to control future capital expenditures. The actual inventory level will depend on the inventory that our distributors decide to hold to support their customers, overall demand for our products and our production levels. |
• | Capital expenditures for the quarter ending June 30, 2012 are expected to be approximately $18 million. Capital expenditures for all of fiscal year 2013 are anticipated to be approximately $70 million. We are continuing to take actions to invest in the equipment needed to support the expected growth of our new products and technologies. |
• | We expect net cash generation during the June quarter of approximately $100 million to $110 million prior to the dividend payment. |
1 | Use of Non-GAAP Financial Measures: Our Non-GAAP adjustments, where applicable, include the effect of share-based compensation, expenses related to our acquisition activities (including intangible asset amortization, inventory valuation costs, severance costs, earn-out adjustments and legal and other general and administrative expenses associated with acquisitions), losses on equity securities, and non-cash interest expense on our convertible debentures, the related income tax implications of these items and nonrecurring tax events. |
2 | Diluted Common Shares Outstanding can vary for, among other things, the trading price of our common stock, the actual exercise of options or vesting of restricted stock units, the potential for incremental dilutive shares from our convertible debentures (additional information regarding our share count is available in the investor relations section of our website under the heading “Supplemental Financial Information”), and the repurchase or the issuance of stock. The diluted common shares outstanding presented in the guidance table above assumes an average Microchip stock price in the June 2012 quarter of $36.00 per share (however, we make no prediction as to what our actual share price will be for such period or any other period and we cannot estimate what our stock option exercise activity will be during the quarter). |
3 | Generally, gross margin fluctuates over time, driven primarily by the mix of microcontrollers, analog products and memory products sold and licensing revenue; variances in manufacturing yields; fixed cost absorption; wafer fab loading levels; inventory reserves; pricing pressures in our non-proprietary product lines; and competitive and economic conditions. Operating expenses fluctuate over time, primarily due to net sales and profit levels. |
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES | ||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (in thousands except per share amounts) (Unaudited) | ||||||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Net sales | $ | 338,911 | $ | 379,985 | $ | 1,383,176 | $ | 1,487,205 | ||||||||
Cost of sales | 145,038 | 154,394 | 590,782 | 612,769 | ||||||||||||
Gross profit | 193,873 | 225,591 | 792,394 | 874,436 | ||||||||||||
Operating expenses: | ||||||||||||||||
Research and development | 47,713 | 44,159 | 182,650 | 170,607 | ||||||||||||
Selling, general and administrative | 50,754 | 56,885 | 212,391 | 227,781 | ||||||||||||
Special charges | 1,497 | 186 | 837 | 1,865 | ||||||||||||
99,964 | 101,230 | 395,878 | 400,253 | |||||||||||||
Operating income | 93,909 | 124,361 | 396,516 | 474,183 | ||||||||||||
(Losses) gains on equity method investments | (135 | ) | (28 | ) | (195 | ) | 157 | |||||||||
Other expense, net | (1,852 | ) | (4,304 | ) | (16,626 | ) | (13,642 | ) | ||||||||
Income from continuing operations before income taxes | 91,922 | 120,029 | 379,695 | 460,698 | ||||||||||||
Income tax provision | 11,286 | (10,583 | ) | 42,990 | 31,531 | |||||||||||
Net income from continuing operations | 80,636 | 130,612 | 336,705 | 429,167 | ||||||||||||
Discontinued operations: | ||||||||||||||||
Loss from discontinued operations before income taxes | - | (5,754 | ) | - | (11,126 | ) | ||||||||||
Income tax benefit | - | (670 | ) | - | (909 | ) | ||||||||||
Net loss from discontinued operations | - | (5,084 | ) | - | (10,217 | ) | ||||||||||
Net income | $ | 80,636 | $ | 125,528 | $ | 336,705 | $ | 418,950 | ||||||||
Basic net income per common share continuing operations | $ | 0.42 | $ | 0.69 | $ | 1.76 | $ | 2.29 | ||||||||
Basic net loss per common share discontinued operations | - | (0.03 | ) | - | (0.05 | ) | ||||||||||
Basic net income per common share | $ | 0.42 | $ | 0.66 | $ | 1.76 | $ | 2.24 | ||||||||
Diluted net income per common share continuing operations | $ | 0.39 | $ | 0.65 | $ | 1.65 | $ | 2.2 | ||||||||
Diluted net loss per common share discontinued operations | - | (0.03 | ) | - | (0.05 | ) | ||||||||||
Diluted net income per common share | $ | 0.39 | $ | 0.62 | $ | 1.65 | $ | 2.15 | ||||||||
Basic common shares outstanding | 192,570 | 188,933 | 191,283 | 187,066 | ||||||||||||
Diluted common shares outstanding | 206,017 | 201,829 | 203,519 | 194,715 |
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) | |||||||
ASSETS | |||||||
March 31, | March 31, | ||||||
2012 | 2011 | ||||||
(Unaudited) | |||||||
Cash and short-term investments | $ | 1,459,009 | $ | 1,243,496 | |||
Accounts receivable, net | 170,201 | 181,202 | |||||
Inventories | 217,278 | 180,800 | |||||
Other current assets | 169,373 | 169,485 | |||||
Total current assets | 2,015,861 | 1,774,983 | |||||
Property, plant & equipment, net | 516,611 | 540,513 | |||||
Long-term investments | 328,586 | 464,838 | |||||
Other assets | 222,718 | 187,724 | |||||
Total assets | $ | 3,083,776 | $ | 2,968,058 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Accounts payable and other current liabilities | $ | 139,164 | $ | 200,272 | |||
Deferred income on shipments to distributors | 108,709 | 140,044 | |||||
Total current liabilities | 247,873 | 340,316 | |||||
Convertible debentures | 355,050 | 347,334 | |||||
Long-term income tax payable | 70,490 | 58,125 | |||||
Deferred tax liability | 411,368 | 399,527 | |||||
Other long-term liabilities | 8,322 | 10,318 | |||||
Stockholders’ equity | 1,990,673 | 1,812,438 | |||||
Total liabilities and stockholders’ equity | $ | 3,083,776 | $ | 2,968,058 |
Three Months Ended March 31, | Twelve Months Ended March 31, | ||||||||||||||
2012 | 2011 | 2012 | 2011 | ||||||||||||
Gross profit, as reported | $ | 193,873 | $ | 225,591 | $ | 792,394 | $ | 874,436 | |||||||
Share-based compensation expense | 1,272 | 1,409 | 5,648 | 6,825 | |||||||||||
Acquisition-related acquired inventory valuation costs and intangible asset amortization | 1,773 | 1,861 | 6,900 | 12,887 | |||||||||||
Non-GAAP gross profit | $ | 196,918 | $ | 228,861 | $ | 804,942 | $ | 894,148 | |||||||
Non-GAAP gross profit percentage | 58.1 | % | 60.2 | % | 58.2 | % | 60.1 | % |
Three Months Ended March 31, | Twelve Months Ended March 31, | ||||||||||||||
2012 | 2011 | 2012 | 2011 | ||||||||||||
Research and development expenses, as reported | $ | 47,713 | $ | 44,159 | $ | 182,650 | $ | 170,607 | |||||||
Share-based compensation expense | (3,899 | ) | (3,358 | ) | (14,719 | ) | (12,874 | ) | |||||||
Non-GAAP research and development expenses | $ | 43,814 | $ | 40,801 | $ | 167,931 | $ | 157,733 | |||||||
Non-GAAP research and development expenses as a percentage of net sales | 12.9 | % | 10.7 | % | 12.1 | % | 10.6 | % |
Three Months Ended March 31, | Twelve Months Ended March 31, | ||||||||||||||
2012 | 2011 | 2012 | 2011 | ||||||||||||
Selling, general and administrative expenses,as reported | $ | 50,754 | $ | 56,885 | $ | 212,391 | $ | 227,781 | |||||||
Share-based compensation expense | (4,648 | ) | (4,260 | ) | (17,922 | ) | (17,113 | ) | |||||||
Acquisition-related intangible asset amortization and other costs | (983 | ) | (1,861 | ) | (4,880 | ) | (8,593 | ) | |||||||
Non-GAAP selling, general and administrative expenses | $ | 45,123 | $ | 50,764 | $ | 189,589 | $ | 202,075 | |||||||
Non-GAAP selling, general and administrative expenses as a percentage of net sales | 13.3 | % | 13.4 | % | 13.7 | % | 13.6 | % |
Three Months Ended March 31, | Twelve Months Ended March 31, | ||||||||||||||
2012 | 2011 | 2012 | 2011 | ||||||||||||
Operating income, as reported | $ | 93,909 | $ | 124,361 | $ | 396,516 | $ | 474,183 | |||||||
Share-based compensation expense | 9,819 | 9,027 | 38,289 | 36,812 | |||||||||||
Acquisition-related acquired inventory valuation costs, intangible asset amortization and other costs | 2,756 | 3,722 | 11,780 | 21,480 | |||||||||||
Special charges | 1,497 | 186 | 837 | 1,865 | |||||||||||
Non-GAAP operating income | $ | 107,981 | $ | 137,296 | $ | 447,422 | $ | 534,340 | |||||||
Non-GAAP operating income as a percentage of net sales | 31.9 | % | 36.1 | % | 32.3 | % | 35.9 | % |
Three Months Ended March 31, | Twelve Months Ended March 31, | ||||||||||||||
2012 | 2011 | 2012 | 2011 | ||||||||||||
Other expense, net, as reported | $ | (1,852 | ) | $ | (4,304 | ) | $ | (16,626 | ) | $ | (13,642 | ) | |||
Convertible debt non-cash interest expense | 1,932 | 1,746 | 7,512 | 6,846 | |||||||||||
Losses on equity securities | - | - | 1,878 | - | |||||||||||
Non-GAAP other income (expense), net | $ | 80 | $ | (2,558 | ) | $ | (7,236 | ) | $ | (6,796 | ) | ||||
Non-GAAP other income (expense), net, as a percentage of net sales | 0.0 | % | (0.7 | )% | (0.5 | )% | (0.5 | )% |
Three Months Ended March 31, | Twelve Months Ended March 31, | ||||||||||||||
2012 | 2011 | 2012 | 2011 | ||||||||||||
Income tax provision, as reported | $ | 11,286 | $ | (10,583 | ) | $ | 42,990 | $ | 31,531 | ||||||
Income tax rate, as reported | 12.3 | % | -8.8 | % | 11.3 | % | 6.8 | % | |||||||
Share-based compensation expense | 1,234 | 1,051 | 4,889 | 4,493 | |||||||||||
Acquisition-related acquired inventory valuation costs, intangible asset amortization and other costs | 192 | 151 | 656 | 714 | |||||||||||
Special charges | 146 | 22 | 146 | 159 | |||||||||||
Convertible debt non-cash interest expense | 724 | 655 | 2,817 | 2,567 | |||||||||||
Net tax benefit of IRS settlement, R&D tax credit reinstatement, and other tax matters | - | 24,395 | 4,075 | 25,929 | |||||||||||
Losses on equity securities | - | - | 704 | - | |||||||||||
Non-GAAP income tax provision | $ | 13,582 | $ | 15,691 | $ | 56,277 | $ | 65,393 | |||||||
Non-GAAP income tax rate | 12.6 | % | 11.6 | % | 12.8 | % | 12.4 | % |
Three Months Ended March 31, 2012 | Three Months Ended March 31, 2011 | Twelve Months Ended March 31, 2012 | Twelve Months Ended March 31, 2011 | ||||||||||||||||||||||||||||
Consolidated Operations | Consolidated Operations | Continuing Operations | Discontinued Operations | Consolidated Operations | Consolidated Operations | Continuing Operations | Discontinued Operations | ||||||||||||||||||||||||
Net income (loss), as reported | $ | 80,636 | $ | 125,528 | $ | 130,612 | $ | (5,084 | ) | $ | 336,705 | $ | 418,950 | $ | 429,167 | $ | (10,217 | ) | |||||||||||||
Share-based compensation expense, net of tax effect | 8,585 | 7,976 | 7,976 | - | 33,400 | 32,319 | 32,319 | - | |||||||||||||||||||||||
Acquisition-related acquired inventory valuation costs, intangible asset amortization and other costs, net of tax effect | 2,564 | 3,571 | 3,571 | - | 11,124 | 23,454 | 20,766 | 2,688 | |||||||||||||||||||||||
Special charges, net of tax effect | 1,351 | 164 | 164 | - | 691 | 1,706 | 1,706 | - | |||||||||||||||||||||||
Net tax benefit of IRS settlement R&D tax credit reinstatement and other tax matters | - | (24,395 | ) | (24,395 | ) | - | (4,075 | ) | (25,929 | ) | (25,929 | ) | - | ||||||||||||||||||
Convertible debt non-cash interest expense, net of tax effect | 1,208 | 1,091 | 1,091 | - | 4,695 | 4,279 | 4,279 | - | |||||||||||||||||||||||
Losses on equity securities, net of tax effect | - | - | - | - | 1,174 | - | - | - | |||||||||||||||||||||||
Non-GAAP net income (loss) | $ | 94,344 | $ | 113,935 | $ | 119,019 | $ | (5,084 | ) | $ | 383,714 | $ | 454,779 | $ | 462,308 | $ | (7,529 | ) | |||||||||||||
Non-GAAP net income (loss) as a percentage of net sales | 27.8 | % | 31.3 | % | 27.7% | 31.1% | |||||||||||||||||||||||||
Diluted net income (loss) per share, as reported | $ | 0.39 | $ | 0.62 | $ | 0.65 | $ | (0.03 | ) | $ | 1.65 | $ | 2.15 | $ | 2.20 | $(0.05) | |||||||||||||||
Non-GAAP diluted net income (loss) per share | $ | 0.46 | $ | 0.57 | $ | 0.59 | $ | (0.03 | ) | $ | 1.89 | $ | 2.35 | $ | 2.39 | (0.04 | ) | ||||||||||||||
Diluted common shares outstanding Non-GAAP | 205,603 | 201,133 | 201,133 | 201,133 | 202,969 | 193,665 | 193,665 | 193,665 |